The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-Cyano-4-methyl-2-oxo-2H-chromen-7-yl 3-nitrobenzenesulfonate ID: ALA4091160
PubChem CID: 137642382
Max Phase: Preclinical
Molecular Formula: C17H10N2O7S
Molecular Weight: 386.34
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1c(C#N)c(=O)oc2cc(OS(=O)(=O)c3cccc([N+](=O)[O-])c3)ccc12
Standard InChI: InChI=1S/C17H10N2O7S/c1-10-14-6-5-12(8-16(14)25-17(20)15(10)9-18)26-27(23,24)13-4-2-3-11(7-13)19(21)22/h2-8H,1H3
Standard InChI Key: FKONMHGNDAFPBS-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
4.4863 -19.5218 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.8990 -20.2317 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
5.3074 -19.5193 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.3174 -19.4144 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3162 -20.2340 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0243 -20.6429 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0225 -19.0056 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7311 -19.4108 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7345 -20.2315 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4429 -20.6366 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.1525 -20.2257 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1492 -19.4050 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4362 -18.9954 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4317 -18.1782 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8614 -20.6323 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.6082 -20.6420 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.1928 -20.6409 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8515 -18.9957 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5579 -18.5849 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.4860 -20.2317 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7802 -20.6402 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7811 -21.4574 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4936 -21.8642 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1964 -21.4533 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4984 -22.6846 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.2082 -23.0896 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.7928 -23.0968 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 9 2 0
8 7 2 0
7 4 1 0
8 9 1 0
8 13 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 2 0
13 14 1 0
11 15 2 0
5 16 1 0
16 2 1 0
2 17 1 0
18 19 3 0
12 18 1 0
17 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 17 1 0
25 26 2 0
25 27 1 0
23 25 1 0
M CHG 2 25 1 27 -1
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 386.34Molecular Weight (Monoisotopic): 386.0209AlogP: 2.65#Rotatable Bonds: 4Polar Surface Area: 140.51Molecular Species: NEUTRALHBA: 8HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 3.05CX LogD: 3.05Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.29Np Likeness Score: -1.17
References 1. Salar U, Khan KM, Iqbal J, Ejaz SA, Hameed A, Al-Rashida M, Perveen S, Tahir MN.. (2017) Coumarin sulfonates: New alkaline phosphatase inhibitors; in vitro and in silico studies., 131 [PMID:28288318 ] [10.1016/j.ejmech.2017.03.003 ]